Results 31 to 40 of about 2,389,723 (301)
BMC Health Services Research, 2023 Background We determined the cost-effectiveness of the anti-vascular endothelial growth factor (VEGF) intravitreal injection versus panretinal photocoagulation (PRP) for patients with proliferative diabetic retinopathy (PDR) in South Korea.
Hyeon-Jeong Lee +5 more
doaj +1 more source
Anti-VEGF Therapies in the Clinic [PDF]
Cold Spring Harbor Perspectives in Medicine, 2012 The development and use of antiangiogenesis agents, particularly those targeting vascular endothelial growth factor (VEGF), has become an integral component of anticancer regimens for many tumor types. This review is intended to highlight some of the most important clinical successes and failures of anti-VEGF therapies, and where possible, to suggest ...
Kellen L, Meadows, Herbert I, Hurwitz
openaire +2 more sources
Refractive status and ocular characteristics of preschool children with retinopathy of prematurity after different treatments [PDF]
International Journal of OphthalmologyAIM: To compare the changes in preschool refractive status, ocular biological parameters, and higher-order aberrations in children with retinopathy of prematurity (ROP) after retinal laser photocoagulation or anti-vascular endothelial growth factor (anti-
Wu-Yang Jiang +5 more
doaj +1 more source
Indian Journal of Ophthalmology, 2023 Intravitreal injection of anti- Vascular Endothelial Growth Factor (VEGF)is commonly used to treat patients with diabetic macular edema (DME). However, the injection alone requires high cost and compliance.
Parangeni M Lubis +2 more
doaj +1 more source
Data of- QOL among patients on Anti-VEGF
, 2023 The present data set is of the study on Quality of Life and financial burden among patients receiving anti-VEGF ...
Dr Sanjay Kini B (15901601) +1 more
core +1 more source
BMJ Open, 2022 Aims The arrival of anti-vascular endothelial growth factor (anti-VEGF) therapies represented a treatment shift for several ophthalmological disorders and led to an increasing number of patients undergoing intravitreal injections.
Ana Patricia Marques +8 more
doaj +1 more source
Anti-VEGF reduces inflammatory features in macular edema secondary to retinal vein occlusion [PDF]
International Journal of Ophthalmology, 2022 AIM: To investigate the anti-inflammatory effect of intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) in patients with macular edema secondary to retinal vein occlusion (RVO-ME).
Hai-Feng Qin +12 more
doaj +1 more source
VEGF family members : modulators of tumor angiogenesis and lymphangiogenesis [PDF]
, 2006 Members of the vascular endothelial growth factor (VEGF) family and their receptors (VEGFR) play an essential role in the development and maintenance of the blood and lymphatic vasculature.
Kopfstein, Lucie
core +1 more source
Frontiers in Pharmacology, 2023 Purpose: To assess functional and anatomical outcomes of intravitreal anti-Vascular Endothelial Growth Factor (anti-VEGF) monotherapy versus combined with verteporfin Photodynamic Therapy (PDT) for Retinal Angiomatous Proliferation (RAP).Methods: Studies
Matteo Fallico +16 more
doaj +1 more source
Clinical significance of VEGF-A, -C and -D expression in esophageal malignancies [PDF]
, 2005 Vascular endothelial growth factors ( VEGF)- A, - C and - D are members of the proangiogenic VEGF family of glycoproteins. VEGF-A is known to be the most important angiogenic factor under physiological and pathological conditions, while VEGF-C and VEGF-D
Jauch, Karl-Walter +2 more
core +1 more source